Composition
- Active substance
- agomelatine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Thymanax
- Active substance
- agomelatine
- Therapeutic area
- Depressive Disorder, Major
- Marketing authorisation holder
- Les Laboratoires Servier
- Status
- Refused
- Refused
- 16 Jan 2007
- EMA product number
- EMEA/H/C/000657
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No
- Generic
- No
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No